Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug–Resistant Acinetobacter baumannii Infections: A Drug Pair Limiting the Development of Resistance

Polymyxins are considered as last–resort antibiotics to treat infections caused by Acinetobacter baumannii. However, there are increasing reports of resistance in A. baumannii to polymyxins. In this study, inhalable combinational dry powders consisting of ciprofloxacin (CIP) and polymyxin B (PMB) we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junwei, Stegger, Marc, Moodley, Arshnee, Yang, Mingshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056848/
https://www.ncbi.nlm.nih.gov/pubmed/36986580
http://dx.doi.org/10.3390/pharmaceutics15030720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056848/
https://www.ncbi.nlm.nih.gov/pubmed/36986580
http://dx.doi.org/10.3390/pharmaceutics15030720

Ejemplares similares